TickerFacts.

BioCorRx Inc. (BICX): R&D Expense

Annual figures by period end, from SEC filings.

$1.77M
Year ended 2025-12-31
$2.37M
Trailing 12 months to 2026-06-30
+6.6%
3-year compound annual growth
-16.2%
5-year compound annual growth
$4.27M2017-12-31: $450.7K2018-12-31: $151.8K2019-12-31: $1.13M2020-12-31: $4.27M2021-12-31: $1.61M2022-12-31: $1.46M2023-12-31: $891.1K2024-12-31: $1.48M2025-12-31: $1.77M$1.77M
2017-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$1.77M+19.3%2026-03-31, From 2025-01-01
2024-12-31$1.48M+66.4%2026-03-31, From 2024-01-01
2023-12-31$891.1K-38.9%2025-03-31, From 2023-01-01
2022-12-31$1.46M-9.1%2024-04-01, From 2022-01-01
2021-12-31$1.61M-62.4%2023-03-31, From 2021-01-01
2020-12-31$4.27M+279.9%2022-03-31, From 2020-01-01
2019-12-31$1.13M+641.3%2021-03-31, From 2019-01-01
2018-12-31$151.8K-66.3%2020-03-30, From 2018-01-01
2017-12-31$450.7Kn/a2019-04-16, From 2017-01-01